Zobrazeno 1 - 10
of 2 642
pro vyhledávání: '"Medin, J."'
Autor:
Wahlström M; Karolinska Institutet, Department of Clinical Sciences, Department of Cardiology, Danderyd Hospital, Stockholm, Sweden.; Department of Health Promoting Science, Sophiahemmet University, Box 5035, 114 86 Stockholm, Sweden., Medin J; Department of Health Promoting Science, Sophiahemmet University, Box 5035, 114 86 Stockholm, Sweden.; Department of Health Sciences, Mid Sweden University, Östersund, Sweden., Karlsson MR; Karolinska Institutet, Department of Clinical Sciences, Department of Cardiology, Danderyd Hospital, Stockholm, Sweden.; Ersta Sköndal Bräcke University College, Stockholm, Sweden.
Publikováno v:
International journal of cardiology. Heart & vasculature [Int J Cardiol Heart Vasc] 2023 Sep 22; Vol. 49, pp. 101274. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
Autor:
Svirelis J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Adali Z; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Emilsson G; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Medin J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Andersson J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Vattikunta R; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Hulander M; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Järlebark J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Kolman K; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Olsson O; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden., Sakiyama Y; Biozentrum and the Swiss Nanoscience Institute, University of Basel, 4056, Basel, Switzerland., Lim RYH; Biozentrum and the Swiss Nanoscience Institute, University of Basel, 4056, Basel, Switzerland., Dahlin A; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296, Gothenburg, Sweden. adahlin@chalmers.se.
Publikováno v:
Nature communications [Nat Commun] 2023 Aug 23; Vol. 14 (1), pp. 5131. Date of Electronic Publication: 2023 Aug 23.
Autor:
Müllerová H; Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK hana.muellerova@astrazeneca.com., Medin J; Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Arnold M; Real World Evidence Data and Analytics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Gomes da Silva H; Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Kumar S; Real World Evidence Data and Analytics, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA., Nord M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden., Hubbard R; Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Publikováno v:
BMJ open [BMJ Open] 2023 Jan 13; Vol. 13 (1), pp. e063645. Date of Electronic Publication: 2023 Jan 13.
Publikováno v:
In Nuclear Inst. and Methods in Physics Research, A 2007 580(1):466-468
Autor:
Gellerstedt L; Department of Health Promoting Science, Sophiahemmet University, Stockholm, Sweden.; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Medin J; Department of Health Promoting Science, Sophiahemmet University, Stockholm, Sweden.; Swedish Red Cross University, Huddinge, Sweden., Kumlin M; Department of Health Promoting Science, Sophiahemmet University, Stockholm, Sweden.; Unit for Experimental Asthma and Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Rydell Karlsson M; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.; Ersta Sköndal Bräcke University College, Stockholm, Sweden.
Publikováno v:
Journal of clinical nursing [J Clin Nurs] 2019 Oct; Vol. 28 (19-20), pp. 3400-3407. Date of Electronic Publication: 2019 Jun 10.
Autor:
Denard, J., Marinello, M., Latournerie, V., Bonnin, D., Derome, M., Martin, S., Medin, J., Bello, A. Buj
Publikováno v:
In Neuromuscular Disorders October 2022 32 Supplement 1:S94-S94
Autor:
Palmans H; Medical Physics, MedAustron Ion Therapy Center, Wiener Neustadt, Austria.; Medical Radiation Science, National Physical Laboratory, Teddington, United Kingdom., Lourenço A; Medical Radiation Science, National Physical Laboratory, Teddington, United Kingdom.; University College London, London, United Kingdom., Medin J; Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden.; Department of Medical Radiation Physics, Clinical Sciences, Lund, Lund University, Lund, Sweden., Vatnitsky S; Medical Physics, MedAustron Ion Therapy Center, Wiener Neustadt, Austria., Andreo P; Departmentof Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Physics in medicine and biology [Phys Med Biol] 2022 Sep 29; Vol. 67 (19). Date of Electronic Publication: 2022 Sep 29.
Autor:
Andersson J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology 41296 Gothenburg Sweden adahlin@chalmers.se., Svirelis J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology 41296 Gothenburg Sweden adahlin@chalmers.se., Medin J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology 41296 Gothenburg Sweden adahlin@chalmers.se., Järlebark J; Department of Chemistry and Chemical Engineering, Chalmers University of Technology 41296 Gothenburg Sweden adahlin@chalmers.se., Hailes R; Department of Chemistry and Chemical Engineering, Chalmers University of Technology 41296 Gothenburg Sweden adahlin@chalmers.se., Dahlin A; Department of Chemistry and Chemical Engineering, Chalmers University of Technology 41296 Gothenburg Sweden adahlin@chalmers.se.
Publikováno v:
Nanoscale advances [Nanoscale Adv] 2022 Sep 13; Vol. 4 (23), pp. 4925-4937. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Autor:
Laffan MA; Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, Room 5S5b, The Hammersmith Hospital, Hammersmith Campus, Du Cane Road, London W12 0NN, UK. Electronic address: m.laffan@imperial.ac.uk., Rees S; Sue Rees Consultancy Ltd, Verulam Point, Station Way, St. Albans AL1 5HE, UK. Electronic address: sue.rees22@btinternet.com., Yadavalli M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD 20878, USA. Electronic address: madhavi.yadavalli@astrazeneca.com., Ferstenberg LB; Patient Safety, Chief Medical Office, R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD 20878, USA. Electronic address: lisabeth.ferstenberg@astrazeneca.com., Kumar Shankar N; Patient Safety, Chief Medical Office, R&D, AstraZeneca, India Pvt. Ltd, Rachenahalli, Outer Ring Road, Bangalore 560045, India. Electronic address: nirmalkumar.shankar@astrazeneca.com., Medin J; BioPharmaceuticals Medical, AstraZeneca, Pepparedsleden 1, Mölndal SE431 83, Gothenburg, Sweden. Electronic address: jennie.medin@astrazeneca.com., Foskett N; BioPharmaceuticals Medical, AstraZeneca, Academy House 136 Hills Road, Cambridge CB2 8PA, UK. Electronic address: nadia.foskett@astrazeneca.com., Arnold M; BioPharmaceuticals Medical, AstraZeneca, Granta Park, Cambridge CB21 6GP, UK. Electronic address: matthew.arnold2@astrazeneca.com., Gomes da Silva H; Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Rua Humberto Madeira 7 / 7A, 2730-097 Lisboa, Portugal. Electronic address: hugo.gomesdasilva@astrazeneca.com., Bhuyan P; Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD 20878, USA. Electronic address: prakash.bhuyan@astrazeneca.com., Nord M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Pepparedsleden 1, Mölndal SE431 83, Gothenburg, Sweden. Electronic address: magnus.nord@astrazeneca.com.
Publikováno v:
Vaccine [Vaccine] 2022 Sep 09; Vol. 40 (38), pp. 5585-5593. Date of Electronic Publication: 2022 Aug 19.
Publikováno v:
In Radiotherapy and Oncology May 2022 170 Supplement 1:S698-S698